US 9404113
Antisense modulation of PTP1B expression
granted A61KA61K31/7088A61P
Quick answer
US patent 9404113 (Antisense modulation of PTP1B expression) held by Ionis Pharmaceuticals, Inc. expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/7088, A61P, A61P3/00, A61P3/04